Compare Vaxcyte Inc. Common Stock (PCVX) vs SailPoint Inc. Common Stock (SAIL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Vaxcyte Inc. Common Stock vs SailPoint Inc. Common Stock — how do they compare? Vaxcyte Inc. Common Stock trades at $67.27 (market cap $10.51B), while SailPoint Inc. Common Stock trades at $19 (market cap $11.06B). The key difference: Vaxcyte Inc. Common Stock and SailPoint Inc. Common Stock are close in size by market cap, and Vaxcyte Inc. Common Stock is trading nearer its 52-week high, SailPoint Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Vaxcyte Inc. Common Stock for 0 Days and SailPoint Inc. Common Stock for 0 Days on average.
| PCVX | SAIL | |
|---|---|---|
Market Cap | $10.51B | $11.06B |
Volume | 2,644,694 | 3,269,663 |
Sector | Health | Technology |
52-Week High | $73.82 | $22.85 |
52-Week Low | $40.32 | $10.49 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $9.14B | $10.76B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Vaxcyte Inc. Common Stock
Vaxcyte, Inc. is a clinical-stage vaccine company that engineers protein-based vaccines to prevent bacterial diseases such as invasive pneumococcal disease, using its proprietary cell-free protein synthesis platform to develop candidates including the pneumococcal conjugate vaccines VAX-31 and VAX-24.
Read more on PCVX →About SailPoint Inc. Common Stock
SailPoint, Inc. develops identity security software that helps enterprises manage and govern access to applications and data across users, machines, and AI agents. Its unified identity security platform combines automation and intelligence to control identity-related risk at scale for large organizations.
Read more on SAIL →
